Skip to main content

Sotera Health Co

For the period ended Dec 31, 2024. Filed Feb 27, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 27, 2025

SHC$16.44+2.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

(in thousands, except per share amounts)

As of December 31,
20242023
Assets
Current assets:
Cash and cash equivalents$277,242$296,407
Restricted cash short-term1,6235,247
Accounts receivable, net of allowance for uncollectible accounts of $2,532 and $4,689 as of December 31, 2024 and 2023, respectively140,327147,696
Inventories, net49,15848,316
Prepaid expenses and other current assets51,03153,846
Income taxes receivable6,6565,732
Total current assets526,037557,244
Property, plant, and equipment, net1,036,892946,914
Operating lease assets27,55124,037
Deferred income taxes2,8654,993
Post-retirement assets42,52428,482
Other assets37,05341,242
Other intangible assets, net317,653416,318
Goodwill1,081,0731,111,190
Total assets$3,071,648$3,130,420
Liabilities and equity
Current liabilities:
Accounts payable$55,098$71,039
Accrued liabilities90,463122,471
Deferred revenue15,10013,492
Current portion of long-term debt14,8034,797
Current portion of finance lease obligations2,9238,771
Current portion of operating lease obligations5,0565,934
Income taxes payable7,5594,150
Total current liabilities191,002230,654
Long-term debt2,208,1002,223,674
Finance lease obligations, less current portion95,28663,793
Operating lease obligations, less current portion24,46520,087
Noncurrent asset retirement obligations49,31947,944
Deferred lease income16,78418,762
Post-retirement obligations7,8638,439
Noncurrent liabilities4,4188,879
Deferred income taxes69,50064,454
Total liabilities2,666,7372,686,686
See Commitments and contingencies note
Equity:
Common stock, with $0.01 par value, 1,200,000 shares authorized; 286,037 shares issued at December 31, 2024 and 20232,8602,860
Preferred stock, with $0.01 par value, 120,000 shares authorized; no shares issued at December 31, 2024 and 2023——
Treasury stock, at cost (2,571 and 3,207 shares at December 31, 2024 and 2023, respectively)(23,434)(27,182)
Additional paid-in capital1,243,7781,215,178
Retained deficit(610,042)(654,440)
Accumulated other comprehensive loss(208,251)(92,682)
Total equity404,911443,734
Total liabilities and equity$3,071,648$3,130,420
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.